This study describes the development and validation of a screening instrument for drug use disorders and negative consequences of drug use for use in primary care clinics.
Mason and coauthors determine if gabapentin increases rates of sustained abstinence and no heavy drinking and decreases alcohol-related insomnia, dysphoria, and craving, in a dose-dependent manner. See the Invited Commentary by Nunes.
Dunkler et al evaluate the association between diet; alcohol, protein, and sodium intake; and incidence or progression of chronic kidney disease among individuals with type 2 diabetes mellitus. See also the invited commentary by Kramer and Chang.